Pumper cover yr eyes for a minute - the following may be construed as a stooge post regarding big pharma:
Pfizer's partnering guidance glossy just released. Needs a close read but fair to say benitec's tt034 is well positioned to appeal, should the data be good.
This glossy confirms Pfizer have now gone 180deg on gene therapies from their same policy about 4 yrs back, and are opening up to nucleaic acid therapies again, excepting oncology. I think worth a close read, as it's a Co. like this making a deal with blt that will bring us great returns.
So we need to know what they are prepared to invest in and what they are not.
